Barbara Kofler Selected Research

Type 2 Galanin Receptor

11/2018	Effects of galanin receptor 2 and receptor 3 knockout in mouse models of acute seizures.
1/2018	Lack of Galanin Receptor 3 Alleviates Psoriasis by Altering Vascularization, Immune Cell Infiltration, and Cytokine Expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara Kofler Research Topics

Disease

46	Neoplasms (Cancer) 04/2021 - 02/2002
11	Inflammation (Inflammations) 12/2021 - 02/2008
11	Neuroblastoma 09/2017 - 02/2002
6	Body Weight (Weight, Body) 12/2021 - 08/2010
6	Carcinogenesis 01/2020 - 04/2008
5	Melanoma (Melanoma, Malignant) 01/2021 - 01/2010
5	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 08/2007
4	Glioma (Gliomas) 01/2020 - 06/2003
4	Ganglioneuroma 09/2013 - 02/2002
4	Pheochromocytoma 01/2011 - 06/2005
4	Edema (Dropsy) 02/2009 - 03/2007
3	Head and Neck Neoplasms (Head and Neck Cancer) 04/2021 - 01/2017
3	Skin Diseases (Skin Disease) 01/2021 - 01/2016
3	Squamous Cell Carcinoma of Head and Neck 09/2020 - 04/2018
3	Meningioma (Meningiomas) 01/2020 - 09/2013
3	Breast Neoplasms (Breast Cancer) 08/2019 - 01/2010
3	Epilepsy (Aura) 06/2015 - 08/2007
3	Carcinoma (Carcinomatosis) 01/2010 - 06/2004
2	Cognitive Dysfunction 01/2020 - 01/2018
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2020 - 01/2010
2	Pain (Aches) 10/2019 - 01/2015
2	Oxyphilic Adenoma (Oncocytoma) 01/2019 - 01/2011
2	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 07/2009
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2017 - 06/2004
2	Brain Neoplasms (Brain Tumor) 08/2017 - 02/2002
2	Neurogenic Inflammation 01/2016 - 02/2008
2	Starvation 06/2015 - 01/2015
2	Obesity 01/2015 - 04/2014
2	Glioblastoma (Glioblastoma Multiforme) 04/2014 - 06/2003
2	Astrocytoma (Pilocytic Astrocytoma) 04/2014 - 09/2013
2	Ganglioneuroblastoma 09/2013 - 01/2006
2	Atrophy 01/2012 - 03/2003
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2011 - 04/2009
2	Paraganglioma (Paragangliomas) 01/2011 - 04/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021
1	Colitis 12/2021
1	Mucositis 04/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Foreign Bodies (Foreign Body) 01/2021
1	Thyroid Neoplasms (Thyroid Cancer) 12/2020
1	Chromosomal Instability (Chromosome Stability) 12/2020
1	Wounds and Injuries (Trauma) 10/2020
1	Nasal Obstruction 10/2020

Drug/Important Bio-Agent (IBA)

20	GalaninIBA 12/2021 - 02/2002
17	Mitochondrial DNA (mtDNA)IBA 07/2020 - 03/2003
13	Peptides (Polypeptides)IBA 12/2021 - 02/2002
12	Galanin Receptors (Galanin Receptor)IBA 12/2021 - 02/2002
11	NeuropeptidesIBA 01/2020 - 02/2002
8	EnzymesIBA 01/2019 - 06/2004
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2016
7	alarinIBA 08/2017 - 01/2006
5	Type 3 Galanin ReceptorIBA 12/2021 - 02/2009
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
5	CarbohydratesIBA 01/2021 - 06/2015
5	Messenger RNA (mRNA)IBA 01/2020 - 06/2003
4	Galanin-Like PeptideIBA 09/2013 - 01/2006
3	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 12/2020 - 02/2016
3	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020 - 01/2011
3	DNA (Deoxyribonucleic Acid)IBA 04/2020 - 01/2014
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2019 - 03/2016
3	Amino Acids FDA Link 08/2019 - 06/2005
3	CytokinesIBA 01/2018 - 02/2008
3	oligomycin sensitivity-conferring protein (complex V)IBA 01/2018 - 06/2004
3	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2011 - 04/2008
2	AntibodiesIBA 01/2020 - 01/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2019 - 01/2010
2	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2019 - 04/2008
2	Type 2 Galanin ReceptorIBA 11/2018 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 01/2018 - 01/2015
2	PorinsIBA 02/2016 - 04/2014
2	Histones (Histone)IBA 01/2015 - 01/2014
2	Luteinizing Hormone (Lutropin)FDA LinkGeneric 09/2013 - 04/2012
2	Pyruvate KinaseIBA 11/2012 - 05/2011
2	LigandsIBA 06/2005 - 02/2002
1	Dextran SulfateIBA 12/2021
1	Sarcosine (Methylglycine)IBA 01/2021
1	tiglylcarnitineIBA 01/2021
1	CeramidesIBA 01/2021
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2021
1	4-cresol sulfateIBA 01/2021
1	beta-AlanineIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Antimycin AIBA 12/2020
1	Indicators and Reagents (Reagents)IBA 09/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2020
1	Oncogene Proteins (Oncogene Protein)IBA 08/2020

Therapy/Procedure

16	Therapeutics 01/2021 - 01/2012
12	Ketogenic Diet 01/2020 - 01/2015
4	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 01/2021 - 01/2015
3	Drug Therapy (Chemotherapy) 08/2019 - 06/2015
2	Radiotherapy 04/2021 - 06/2015
2	Chemoradiotherapy 04/2021 - 09/2020
2	Lasers (Laser) 04/2018 - 01/2014
1	Low-Level Light Therapy (LLLT) 04/2021
1	Tattooing 01/2021
1	Nasal Surgical Procedures 10/2020